For example, some T2D treatments, such as insulin, directly regulate the immune system [28], while others, such as SGLT2 inhibitors and metformin, may impact the gut microbiome and indirectly modulate the immune response [29]. Here, SLC5A2 is linked to type 2 diabetes mellitus.